Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03691012 | Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer | unknown | — | 118 | Walter and Eliza Hall Institute of Medical ResearchOTHER | 2 | May 9, 2023 | clinicaltrials |
| NCT05354882 | Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology(DEFACTO2) | unknown | N/A | 150 | Université Sorbonne Paris NordOTHER |
| 1 |
| May 9, 2023 |
| clinicaltrials |
| NCT05824494 | Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors | unknown | Phase 2 | 58 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | May 6, 2023 | clinicaltrials |
| NCT05823402 | Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)(SPECTacular) | unknown | N/A | 30 | BAMF HealthOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05840029 | VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES | unknown | — | 68 | Alexandria UniversityOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05841992 | Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients | unknown | Phase 2 / Phase 3 | 100 | Peking Union Medical College HospitalOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT04240262 | Microwave Ablation for Leiomyoma(MYOMIC2) | unknown | — | 200 | Karolinska InstitutetOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT04880681 | Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle | unknown | N/A | 60 | Region SkaneOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT05246774 | Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer(RABBIO) | unknown | — | 60 | Direction Centrale du Service de Santé des ArméesOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05818631 | Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer | unknown | — | 300 | José Joaquín MiraOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT05430906 | AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer | unknown | Phase 2 | 40 | Hunan Cancer HospitalOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT03774901 | Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma(PULSE) | unknown | Phase 2 | 32 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05822726 | The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate Cancer | unknown | N/A | 240 | Ruijin HospitalOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05823194 | Infertility and Pregnancy Outcomes of Fertility Spared Gynecological Oncology Patients | unknown | N/A | 50 | Acibadem UniversityOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05824247 | A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer | unknown | — | 60 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT02481648 | Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer(EMMPC) | unknown | N/A | 20 | Vancouver Prostate CentreOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05170087 | Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies | unknown | — | 1,200 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05737004 | Effects of Prostate Cancer on Brain Function | unknown | — | 250 | Shanghai East HospitalOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05819060 | The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab | unknown | Phase 2 | 44 | Fudan UniversityOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05815394 | 177Lu-labeled NY108 SPECT Imaging in Patients | unknown | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05816005 | Performance of Whole Body MRI in Extraplevic Disease Detection in Patients Undergoing Pelvic Exenteration for Gynecological Maligniancies(WHOLE BODY) | unknown | — | 71 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05816668 | Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy(Transamin) | unknown | Phase 3 | 122 | Instituto do Cancer do Estado de São PauloOTHER | 0 | Apr 18, 2023 | clinicaltrials |
| NCT05812677 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Apr 14, 2023 | clinicaltrials |
| NCT05813509 | Individualized Precision Treatment Based on Ovarian Cancer Organoid Model | unknown | N/A | 30 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 14, 2023 | clinicaltrials |
| NCT04792749 | Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer | unknown | Phase 3 | 77 | Samsung Medical CenterOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05766163 | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate(COMPAR-P) | unknown | N/A | 150 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05695690 | Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification | unknown | — | 43 | Assiut UniversityOTHER | 0 | Apr 11, 2023 | clinicaltrials |
| NCT05807672 | Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer(MARF-E) | unknown | — | 150 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 11, 2023 | clinicaltrials |
| NCT05806125 | Clinical Value of the Fertility-preserving Surgery in Cervical Cancer | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT05801263 | ctDNA Methylation for Epithelial Ovarian Cancer | unknown | — | 5,000 | Lei LiOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05801276 | ctDNA Methylation for Detecting Ovarian Cancer | unknown | — | 1,400 | Lei LiOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05801783 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer | unknown | Early Phase 1 | 10 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05801796 | Appraising Medical Trial Experiences of Ovarian Cancer Patients | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Apr 6, 2023 | clinicaltrials |
| NCT05792254 | Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer | unknown | N/A | 30 | Ruijin HospitalOTHER | 0 | Mar 31, 2023 | clinicaltrials |
| NCT00492778 | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer | unknown | Phase 2 | 165 | GOG FoundationNETWORK | 2 | Mar 29, 2023 | clinicaltrials |
| NCT03695809 | The Association of G9a Protein and Clinical Outcome of Patients With Vulvar Cancer | unknown | — | 30 | Far Eastern Memorial HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05789628 | Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Mar 29, 2023 | clinicaltrials |
| NCT04369352 | Register to Describe the Treatment Pattern of Platinum-sensitive Relapsed Epithelial Ovarian Cancer Patients in Austria | unknown | — | 150 | Medical University InnsbruckOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT05776355 | NKG2D CAR-NK & Ovarian Cancer | unknown | N/A | 18 | Hangzhou Cheetah Cell Therapeutics Co., LtdOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT00326456 | MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer | unknown | Phase 3 | 820 | National Cancer Institute, NaplesOTHER | 3 | Mar 27, 2023 | clinicaltrials |
| NCT02599116 | Gastrointestinal Microbiome Study of Appendiceal Cancer | unknown | N/A | 24 | Mercy Medical CenterOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT00660842 | Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer(MITO-7) | unknown | Phase 3 | 800 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT01061619 | Pathway to Diagnosis of Ovarian Cancer(MITO-12) | unknown | — | 400 | National Cancer Institute, NaplesOTHER | 3 | Mar 24, 2023 | clinicaltrials |
| NCT01706120 | Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab(MITO16/MANGO-2) | unknown | Phase 4 | 400 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT01802749 | Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer(MITO16MANGO2b) | unknown | Phase 3 | 406 | National Cancer Institute, NaplesOTHER | 5 | Mar 24, 2023 | clinicaltrials |
| NCT03410784 | Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer(MITO28MaNGOov4) | unknown | Phase 2 | 72 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT03561207 | 3D Prediction of Patient-Specific Response(3D-PREDICT) | unknown | — | 570 | KIYATECINDUSTRY | 1 | Mar 24, 2023 | clinicaltrials |
| NCT05233982 | MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer(MITO 35a) | unknown | Phase 2 | 200 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT05783986 | Developing a MRI-based Deep Learning Model to Predict MMR Status | unknown | — | 600 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Mar 24, 2023 | clinicaltrials |
| NCT04060589 | ReIMAGINE Prostate Cancer Risk | unknown | — | 1,000 | University College, LondonOTHER | 1 | Mar 22, 2023 | clinicaltrials |
Data updated 23 days agoSource updated May 9, 2023source: clinicaltrials